About the Authors
Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa
Health Protection, Hunter New England Population Health, Newcastle, New South Wales, Australia
Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa
Malaria Research Lead Programme, Medical Research Council, Durban, South Africa
Malaria Control Programme, KwaZulu–Natal Provincial Department of Health, South Africa
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Centre of Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
NJW is chairman of the World Health Organization malaria treatment guidelines committee and is on the editorial board of PLoS medicine. The authors have no other conflict of interest to declare.
KIB is the principal investigator of the South East African Combination Antimalarial Therapy (SEACAT) evaluation, within which this study was nested. KIB conceptualised this study and analysed the data, drafted this manuscript, and together with DND, NJW, and BLS designed and interpreted results of all study components. FL supervised the statistical analyses performed. AJ managed data entry and together with SSD conducted preliminary analysis and interpretation of the household survey. UM conducted preliminary analysis and interpretation of sentinel safety data. JT conducted preliminary analysis and interpretation of sentinel hospital morbidity and mortality data. EA and BB assisted in the design, and together with DJM, assisted in the coordination of the in vivo study. All authors revised manuscript critically for substantial intellectual content and have access to all data in the studies reported.